tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joshua Jennings, 185 are a BUY (85.65%), 30 are a HOLD (13.89%), 1 are a SELL (0.46%).
Analyst Joshua Jennings, carries an average stock price target met ratio of 54.29% that have a potential upside of 25% achieved within 232 days. Previously, Joshua Jennings worked at TD COWEN.
Joshua Jennings’s has documented 429 price targets and ratings displayed on 34 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on HUMA, Humacyte at 26-Mar-2025.
Analyst best performing recommendations are on DCBO (DOCEBO).
The best stock recommendation documented was for TMDX (TRANSMEDICS GROUP) at 7/26/2022. The price target of $45 was fulfilled within 10 days with a profit of $8.94 (24.79%) receiving and performance score of 24.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$145
$10.41 (7.73%)
$137
2 months 18 days ago
(17-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
369
Buy
$141
$6.41 (4.76%)
$142
2 months 18 days ago
(17-Jul-2025)
18/22 (81.82%)
$17.33 (14.01%)
376
Buy
$145
$10.41 (7.73%)
$139
2 months 18 days ago
(17-Jul-2025)
6/9 (66.67%)
$21.33 (17.25%)
753
Hold
$140
$5.41 (4.02%)
$130
2 months 20 days ago
(15-Jul-2025)
5/6 (83.33%)
$8.26 (6.27%)
125
Hold
$137
$2.41 (1.79%)
$127
2 months 21 days ago
(14-Jul-2025)
18/20 (90%)
$5.51 (4.19%)
452
What Year was the first public recommendation made by Joshua Jennings?
